Bank of New York Mellon Corp - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 170 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$13,705,318
-57.9%
360,287
+0.8%
0.00%
-57.1%
Q2 2023$32,549,028
+25.8%
357,289
-8.9%
0.01%
+16.7%
Q1 2023$25,882,440
+23.6%
392,396
-3.1%
0.01%
+20.0%
Q4 2022$20,944,566
-24.9%
405,039
-0.8%
0.01%
-28.6%
Q3 2022$27,898,000
+77.2%
408,459
+17.3%
0.01%
+75.0%
Q2 2022$15,743,000
-1.8%
348,150
+10.4%
0.00%
+33.3%
Q1 2022$16,029,000
+13.7%
315,480
+5.8%
0.00%0.0%
Q4 2021$14,098,000
+58.7%
298,193
+10.7%
0.00%
+50.0%
Q3 2021$8,882,000
-46.4%
269,484
+2.8%
0.00%
-33.3%
Q2 2021$16,560,000
+69.9%
262,028
+15.4%
0.00%
+50.0%
Q1 2021$9,746,000
-33.0%
227,134
-10.6%
0.00%
-33.3%
Q4 2020$14,541,000
+102.2%
254,207
+6.6%
0.00%
+50.0%
Q3 2020$7,191,000
-9.6%
238,360
-2.2%
0.00%0.0%
Q2 2020$7,957,000
+23.7%
243,640
+1.5%
0.00%0.0%
Q1 2020$6,430,000
+7.0%
240,019
+22.3%
0.00%0.0%
Q4 2019$6,008,000
+31.2%
196,199
+3.2%
0.00%
+100.0%
Q3 2019$4,581,000
-9.6%
190,126
-5.0%
0.00%0.0%
Q2 2019$5,069,000
+53.2%
200,057
+17.9%
0.00%0.0%
Q1 2019$3,308,000
+64.2%
169,652
+11.1%
0.00%0.0%
Q4 2018$2,015,000
-20.6%
152,720
+7.0%
0.00%0.0%
Q3 2018$2,539,000
-9.3%
142,788
+12.3%
0.00%0.0%
Q2 2018$2,798,000
+262.9%
127,167
+264.5%
0.00%
Q1 2018$771,000
+85.3%
34,887
+82.0%
0.00%
Q4 2017$416,00019,1660.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 1,114,962$63,776,00024.13%
Octagon Capital Advisors LP 548,374$31,367,00010.87%
Ghost Tree Capital, LLC 325,000$18,590,0004.14%
Burrage Capital Management LLC 81,357$4,654,0003.55%
Aufman Associates Inc 53,642$3,068,0002.75%
ACUTA CAPITAL PARTNERS, LLC 167,054$9,555,0002.60%
Cormorant Asset Management, LP 1,866,108$106,741,0002.54%
Tri Locum Partners LP 121,409$6,945,0002.52%
venBio Partners LLC 490,471$28,055,0002.48%
HHLR ADVISORS, LTD. 5,028,289$287,618,0002.29%
View complete list of APELLIS PHARMACEUTICALS INC shareholders